Complications in the clinical course of tako-tsubo cardiomyopathy

https://doi.org/10.1016/j.ijcard.2014.07.002Get rights and content

Abstract

Objective

This study evaluated the frequency, severity and outcome of complications in the clinical course of tako-tsubo cardiomyopathy (TTC).

Background

TTC is regarded as a benign disease since left ventricular (LV) function returns to normal within a short time. However, severe complications have been reported in selected patients.

Methods

From 37 hospitals, 209 patients (189 female, age 69 ± 12 years) were prospectively included in a TTC registry.

Results

Complications developed in 108/209 patients (52%); 23 (11%) had > 2 complications. Complications occurred median 1 day after symptom onset, and 77% were seen within 3 days. Arrhythmias were documented in 45/209 patients (22%) including atrial fibrillation in 32 (15%) and ventricular tachycardia in 17 (8%). Of 8 patients resuscitated (4%), 6 survived. Additional complications were right ventricular involvement (24%), pulmonary edema (13%), cardiogenic shock (7%), transient intraventricular pressure gradients (5%), LV thrombi (3%) and stroke (1%). During hospitalization, 5/209 patients (2.5%) died. Patients with complications were older (70 ± 13 vs 67 ± 10 years, p = 0.012), had a higher heart rate (91 ± 26 vs 83 ± 19/min, p = 0.025), more frequently Q\ waves on the admission ECG (36% vs 21%, p = 0.019) and a lower LV ejection fraction (47 ± 15 vs 54 ± 14%, p = 0.002). Multivariate regression analysis identified Q-waves on admission (OR 2.49, 95% CI 1.23–5.05, p = 0.021) and ejection fraction ≤ 30% (OR 4.03, 95% CI 1.04–15.67, p = 0.022) as independent predictors for complications.

Conclusions

TTC may be associated with severe complications in half of the patients. Since the majority of complications occur up to day 3, monitoring is advisable for this time period.

Introduction

Tako-tsubo cardiomyopathy (TTC) is regarded as a reversible and relatively benign disease [1], [2]. However, some authors reported a high mortality of up to 12% [3], [4], [5], [6], [7] related mainly to the occurrence of malignant arrhythmias and cardiogenic shock [1], [8]. Moreover, other complications such as pulmonary edema, intraventricular pressure gradients sometimes associated with acute mitral regurgitation [1], [9], [10], right ventricular involvement with pleural effusions [3], [11], and intraventricular thrombi resulting in acute stroke [12], [13] or arterial embolism [14] have been described. Due to the fact that most reports comprise relatively small patient numbers, the complication rate varies considerably.

In this study we report the frequency and the spectrum of complications in a large cohort of patients with TTC prospectively included in the registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Section snippets

Patients

Between February 2006 and August 2009, patients were prospectively enrolled in the TTC registry according to the following criteria: 1) acute chest symptoms (angina, dyspnea), syncope or other symptoms in combination with 2) ischemic ECG changes with ST-segment elevation ± T-wave inversion, 3) reversible left ventricular regional wall motion abnormality not corresponding to a single coronary artery territory, and 4) absence of significant coronary artery stenoses > 50% by coronary angiography.

Patient characteristics

A total of 324 patients from 36 German hospitals and 1 hospital in Austria were included in the registry. Complete data on acute treatment and complications were available for the last 209 patients after updating the initial CRF for all more recently published complications in TTC. These 209 patients constitute the study population. Compared to the initial cohort of 115 patients there was no significant difference with regard to age, sex, symptoms, cardiac markers, heart rate, Q waves or

Discussion

This registry prospectively including patients with TTC represents one of the largest patient cohorts with this entity. Our results indicate that TTC is not the benign disease; it was initially thought to be since complications were observed in 52% of the patients. Fortunately, most complications could be treated successfully.

Clinical presentation was an ACS in 86% of our patients with TTC most of whom were women. In this registry, TTC patients both without and with ST segment elevation had a

Conflict of interest statement

There is no potential conflict of interest.

Acknowledgments

The following institutions and investigators participated in the Tako-Tsubo registry initiated by the ALKK: Klinikum Aschaffenburg (W. Pistner, R. Uebis), HELIOS Klinikum Aue (T. Ketteler), Klinikum Augsburg (T. Müller-Honold, W. von Scheidt), Herz- und Gefäß-Klinik Bad Neustadt a. d. Saale (R. Schamberger, S. Kerber), DRK Kliniken Berlin Köpenick (A. Bublak, H.-F. Vöhringer), DRK Kliniken Berlin Westend (R. Schoeller), Unfallkrankenhaus Berlin (G. Calmez), Vivantes Klinikum Am Urban und Im

References (41)

Cited by (128)

  • The impact of ST-segment elevation on the prognosis of patients with Takotsubo cardiomyopathy

    2022, Journal of Electrocardiology
    Citation Excerpt :

    Second, the high rate of beta-blocker usage in our study may have reduced the frequency of LVOTO, since it has been shown that administration of these drugs reduces LVOT gradient in this setting [16,17]; in our study, approximately 84% of patients were discharged on beta-blockers while 30% were receiving these agents at admission. Knowledge regarding the association of initial EKG findings and LV thrombus is limited, although both STE and T-wave inversion have been reported [13,18,19]. Thrombus is found more frequently in TC patients with apical ballooning, supporting our finding that STE group had a trend toward higher LV thrombus formation since patients in this group was more likely to have apical dyskinesia/akinesia [13,18].

View all citing articles on Scopus

All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

View full text